News

Get to know Chaitan Khosla and the unique value of the Stanford IMA

A promising novel drug candidate, designed at the atomic level, could help doctors halt the rise of lethal new drug resistant SARS-CoV-2 variants.

Scientists at Stanford and NYU have published and investigated a new structure of the protein LAG-3 which could enable the development of new cancer treatments.

Stanley Qi and team found that an RNA-targeting CRISPR platform could potentially unveil a relatively low-risk way to advance cell therapies for cancer.

Institute Scholar Jonathan Long is the recipient of the 2024 Sloan Research Fellowship.

Polly Fordyce and team found that highly repetitive regions of junk DNA may be the key to a newly discovered mechanism for gene regulation.

Institute Scholar Monther Abu-Remaileh received the AAA R.R. Bensley Award in Cell Biology for making fundamental discoveries in lysosome biology and neurodegenerative diseases.

Our director Carolyn Bertozzi was elected to the NAE for her work inventing bioorthogonal chemistry to engineer tools for novel biomaterials, diagnostics and drug delivery systems.

Institute Scholar Peter Kim is accelerating the creation of new medicines and you give the world a different future.

Through c-ShARP, Stanford researchers get access to top-notch scientific facilities across campus, including the Sarafan ChEM-H Knowledge Centers.

Institute Scholar Christine Jacobs-Wagner recounts her team's journey to a breakthrough discovery that originally started with a "failed experiment".

Charlotte Bravo (Chemistry ’25), Andrew Yang (Bioengineering & Electrical Engineering, ‘25), and Martin Hoberman (Biology ’25) support the development of anti-fungal drugs.

Nathanael Gray elected into the 2024 Class of Fellows of the AACR Academy for transforming the future of cancer therapeutics.

Peter Kim is on the hunt for a vaccine that fends off not just a single viral strain, but a multitude

Thiam accepted a position at Stanford in May 2022 and is building a new multidisciplinary lab to explore the reengineering of immune cells.

The Next Generation Symposium uses more than its namesake event to improve representation among STEM faculty.